Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 5/2017

01-05-2017 | Clinical Research

Are Readmissions After THA Preventable?

Authors: Douglas S. Weinberg, MD, Matthew J. Kraay, MD, Steven J. Fitzgerald, MD, Vasu Sidagam, MD, Glenn D. Wera, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 5/2017

Login to get access

Abstract

Background

Readmissions after total joint arthroplasty have become a key quality measure in elective surgery in the United States. The Affordable Care Act includes the Hospital Readmission Reduction Program, which calls for reduced payments to hospitals with excessive readmissions. This policy uses a method to determine excess readmission ratios and calculate readmission payment adjustments to hospitals, however, it is unclear whether readmission rates are an effective quality metric. The reasons or conditions associated with readmission after elective THA have been well established but the extent to which readmissions can be prevented after THA remains unclear.

Questions/purposes

(1) Are unplanned readmissions after THA associated with orthopaedic or medical causes? (2) Are these readmissions preventable? (3) When during the course of aftercare are orthopaedic versus medical readmissions more likely to occur?

Methods

We retrospectively evaluated all 1096 elective THAs for osteoarthritis performed between January 1, 2011 and June 30, 2014 at a major academic medical center. Of those, 69 patients (6%) who met inclusion criteria were readmitted in our healthcare system within 90 days of discharge after the index procedure during the study period. Fifty patients were readmitted within 30 days of discharge after the index procedure (5%). We defined a readmission as any unplanned inpatient or observation status admission to the hospital spanning at least one midnight. A panel of physicians not involved in the care of these patients used available criteria and existing consensus guidelines to evaluate the medical records, radiographs, and operative reports to identify whether the underlying reason for readmission was orthopaedic versus medical. They subsequently were classified as either nonpreventable or potentially preventable readmissions, based on any care that may have occurred during the index hospitalization. To make such determinations, consensus specialty society guidelines were used whenever possible for each readmission diagnosis.

Results

A total of 50 of 1096 patients (5% of those who underwent THA during the period in question) were readmitted within 30 days and 69 of 1096 (6%) were readmitted within 90 days of their index procedures. Thirty-one patients were readmitted for orthopaedic reasons (31/69; 45%) and 38 of 69 were readmitted for medical reasons (55%). Three readmissions (three of 69; 4%) were identified as potentially preventable. Of these potentially preventable readmissions, one was orthopaedic (hip dislocation) and two were medical. Thirty-day readmissions were more likely to be orthopaedic than 90-day readmissions (odds ratio, 4.06; 95% CI, 1.18–13.96; p = 0.026).

Conclusions

Using a panel of expert reviewers, available existing criteria, and consensus methodology, it appears only a small percentage of readmissions after THA are potentially preventable. Orthopaedic readmissions occur earlier during the postoperative course. Currently, existing policies and readmission penalties may not serve as valuable external quality metrics. The readmission rates in our study may represent the threshold for expected readmission rates after THA. Future studies should enroll larger numbers of patients and have independent review panels in efforts to refine criteria for what constitutes preventable readmissions.

Level of Evidence

Level III, therapeutic study
Appendix
Available only for authorised users
Literature
1.
go back to reference American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Publishing; 2013.CrossRef American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Publishing; 2013.CrossRef
2.
go back to reference Auerbach AD, Kripalani S, Vasilevskis EE, Sehgal N, Lindenauer PK, Metlay JP, Fletcher G, Ruhnke GW, Flanders SA, Kim C, Williams MV, Thomas L, Giang V, causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med. 2016;176:484–493.CrossRefPubMed Auerbach AD, Kripalani S, Vasilevskis EE, Sehgal N, Lindenauer PK, Metlay JP, Fletcher G, Ruhnke GW, Flanders SA, Kim C, Williams MV, Thomas L, Giang V, causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med. 2016;176:484–493.CrossRefPubMed
3.
go back to reference Avram V, Petruccelli D, Winemaker M, de Beer J. Total joint arthroplasty readmission rates and reasons for 30-day hospital readmission. J Arthroplasty. 2014;29:465–468.CrossRefPubMed Avram V, Petruccelli D, Winemaker M, de Beer J. Total joint arthroplasty readmission rates and reasons for 30-day hospital readmission. J Arthroplasty. 2014;29:465–468.CrossRefPubMed
4.
go back to reference Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.CrossRefPubMed Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.CrossRefPubMed
5.
go back to reference Biedermann R, Tonin A, Krismer M, Rachbauer F, Eibl G, Stockl B. Reducing the risk of dislocation after total hip arthroplasty: the effect of orientation of the acetabular component. J Bone Joint Surg Br. 2005;87:762–769.CrossRefPubMed Biedermann R, Tonin A, Krismer M, Rachbauer F, Eibl G, Stockl B. Reducing the risk of dislocation after total hip arthroplasty: the effect of orientation of the acetabular component. J Bone Joint Surg Br. 2005;87:762–769.CrossRefPubMed
6.
go back to reference Bohl DD, Shen MR, Kayupov E, Della Valle CJ. Hypoalbuminemia independently predicts surgical site infection, pneumonia, length of stay, and readmission after total joint arthroplasty. J Arthroplasty. 2016;31:15–21.CrossRefPubMed Bohl DD, Shen MR, Kayupov E, Della Valle CJ. Hypoalbuminemia independently predicts surgical site infection, pneumonia, length of stay, and readmission after total joint arthroplasty. J Arthroplasty. 2016;31:15–21.CrossRefPubMed
7.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655.CrossRefPubMed
8.
go back to reference Bosco JA 3rd, Karkenny AJ, Hutzler LH, Slover JD, Iorio R. Cost burden of 30-day readmissions following Medicare total hip and knee arthroplasty. J Arthroplasty. 2014;29:903–905.CrossRefPubMed Bosco JA 3rd, Karkenny AJ, Hutzler LH, Slover JD, Iorio R. Cost burden of 30-day readmissions following Medicare total hip and knee arthroplasty. J Arthroplasty. 2014;29:903–905.CrossRefPubMed
9.
go back to reference Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res. 2014;472:188–193.CrossRefPubMed Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res. 2014;472:188–193.CrossRefPubMed
10.
go back to reference Clement RC, Derman PB, Graham DS, Speck RM, Flynn DN, Levin LS, Fleisher LA. Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty. J Arthroplasty. 2013;28(8 suppl):7–10.CrossRefPubMed Clement RC, Derman PB, Graham DS, Speck RM, Flynn DN, Levin LS, Fleisher LA. Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty. J Arthroplasty. 2013;28(8 suppl):7–10.CrossRefPubMed
11.
go back to reference Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR, Li Y. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305:1560–1567.CrossRefPubMedPubMedCentral Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR, Li Y. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305:1560–1567.CrossRefPubMedPubMedCentral
12.
go back to reference Cutrera NJ, Pinkas D, Toro JB. Surgical approaches to the acetabulum and modifications in technique. J Am Acad Orthop Surg. 2015;23:592–603.CrossRefPubMed Cutrera NJ, Pinkas D, Toro JB. Surgical approaches to the acetabulum and modifications in technique. J Am Acad Orthop Surg. 2015;23:592–603.CrossRefPubMed
13.
go back to reference Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ. Risk factors for readmission of orthopaedic surgical patients. J Bone Joint Surg Am. 2013;95:1012–1019.CrossRefPubMed Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ. Risk factors for readmission of orthopaedic surgical patients. J Bone Joint Surg Am. 2013;95:1012–1019.CrossRefPubMed
14.
go back to reference Department of Health and Human Services. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules. Federal Register. 2013;78:5565–5702. Department of Health and Human Services. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules. Federal Register. 2013;78:5565–5702.
15.
go back to reference Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–363.CrossRefPubMedPubMedCentral Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–363.CrossRefPubMedPubMedCentral
16.
go back to reference Elmallah RK, Cherian JJ, Amin H, Jauregui JJ, Pierce TP, Mont MA. Readmission rates in patients who underwent total hip arthroplasty. Surg Technol Int. 2015;27:215–217.PubMed Elmallah RK, Cherian JJ, Amin H, Jauregui JJ, Pierce TP, Mont MA. Readmission rates in patients who underwent total hip arthroplasty. Surg Technol Int. 2015;27:215–217.PubMed
17.
go back to reference Epstein AM. Revisiting readmissions: changing the incentives for shared accountability. N Engl J Med. 2009;360:1457–1459.CrossRefPubMed Epstein AM. Revisiting readmissions: changing the incentives for shared accountability. N Engl J Med. 2009;360:1457–1459.CrossRefPubMed
18.
go back to reference Fischer C, Lingsma HF, Marang-van de Mheen PJ, Kringos DS, Klazinga NS, Steyerberg EW. Is the readmission rate a valid quality indicator? A review of the evidence. PLoS One. 2014;9:e112282.CrossRefPubMedPubMedCentral Fischer C, Lingsma HF, Marang-van de Mheen PJ, Kringos DS, Klazinga NS, Steyerberg EW. Is the readmission rate a valid quality indicator? A review of the evidence. PLoS One. 2014;9:e112282.CrossRefPubMedPubMedCentral
19.
go back to reference Gofton W, Chow J, Olsen KD, Fitch DA. Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique. Int Orthop. 2015;39:847–851.CrossRefPubMed Gofton W, Chow J, Olsen KD, Fitch DA. Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique. Int Orthop. 2015;39:847–851.CrossRefPubMed
20.
go back to reference Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Current evidence does not support Medicare’s 3-day rule in primary total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2015;44:E370–372.PubMed Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Current evidence does not support Medicare’s 3-day rule in primary total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2015;44:E370–372.PubMed
21.
go back to reference Hawk PB. Ready or not: hospital value-based purchasing poised to transform healthcare reimbursement model and introduce new fraud targets under the False Claims Act. Annals Health Law. 2013;22:43. Hawk PB. Ready or not: hospital value-based purchasing poised to transform healthcare reimbursement model and introduce new fraud targets under the False Claims Act. Annals Health Law. 2013;22:43.
22.
go back to reference Healy WL, Iorio R, Clair AJ, Pellegrini VD, Della Valle CJ, Berend KR. Complications of total hip arthroplasty: standardized list, definitions, and stratification developed by The Hip Society. Clin Orthop Relat Res. 2016;474:357–364.CrossRefPubMed Healy WL, Iorio R, Clair AJ, Pellegrini VD, Della Valle CJ, Berend KR. Complications of total hip arthroplasty: standardized list, definitions, and stratification developed by The Hip Society. Clin Orthop Relat Res. 2016;474:357–364.CrossRefPubMed
23.
go back to reference Hechenbleikner EM, Makary MA, Samarov DV, Bennett JL, Gearhart SL, Efron JE, Wick EC. Hospital readmission by method of data collection. J Am Coll Surg. 2013;216:1150–1158.CrossRefPubMed Hechenbleikner EM, Makary MA, Samarov DV, Bennett JL, Gearhart SL, Efron JE, Wick EC. Hospital readmission by method of data collection. J Am Coll Surg. 2013;216:1150–1158.CrossRefPubMed
24.
go back to reference Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res. 2012;470:490–496.CrossRefPubMed Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res. 2012;470:490–496.CrossRefPubMed
25.
go back to reference Issa K, Pivec R, Wuestemann T, Tatevossian T, Nevelos J, Mont MA. Radiographic fit and fill analysis of a new second-generation proximally coated cementless stem compared to its predicate design. J Arthroplasty. 2014;29:192–198.CrossRefPubMed Issa K, Pivec R, Wuestemann T, Tatevossian T, Nevelos J, Mont MA. Radiographic fit and fill analysis of a new second-generation proximally coated cementless stem compared to its predicate design. J Arthroplasty. 2014;29:192–198.CrossRefPubMed
26.
go back to reference Jain N, Johnson T, Morehouse L, Rogers S, Guleri A, Dunkow P. MRSA & MSSA screening for elective lower limb arthroplasty. Bone Joint J Orthop Proc Suppl. 2013;95:205. Jain N, Johnson T, Morehouse L, Rogers S, Guleri A, Dunkow P. MRSA & MSSA screening for elective lower limb arthroplasty. Bone Joint J Orthop Proc Suppl. 2013;95:205.
27.
go back to reference Jorgensen CC, Petersen MA, Kehlet H; Lundbeck Foundation Centre for Fast-Track Hip and Knee Replacement Collaborative Group. Preoperative prediction of potentially preventable morbidity after fast-track hip and knee arthroplasty: a detailed descriptive cohort study. BMJ Open. 2016;6:e009813. Jorgensen CC, Petersen MA, Kehlet H; Lundbeck Foundation Centre for Fast-Track Hip and Knee Replacement Collaborative Group. Preoperative prediction of potentially preventable morbidity after fast-track hip and knee arthroplasty: a detailed descriptive cohort study. BMJ Open. 2016;6:e009813.
28.
go back to reference Joynt KE, Jha AK. Thirty-day readmissions: truth and consequences. N Engl J Med. 2012;366:1366–1369.CrossRefPubMed Joynt KE, Jha AK. Thirty-day readmissions: truth and consequences. N Engl J Med. 2012;366:1366–1369.CrossRefPubMed
29.
go back to reference Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309:342–343.CrossRefPubMed Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309:342–343.CrossRefPubMed
30.
go back to reference Keeney JA, Adelani MA, Nunley RM, Clohisy JC, Barrack RL. Assessing readmission databases: how reliable is the information? J Arthroplasty. 2012;27(8 suppl):72–76.e1-2. Keeney JA, Adelani MA, Nunley RM, Clohisy JC, Barrack RL. Assessing readmission databases: how reliable is the information? J Arthroplasty. 2012;27(8 suppl):72–76.e1-2.
31.
go back to reference Keeney JA, Nam D, Johnson SR, Nunley RM, Clohisy JC, Barrack RL. The impact of risk reduction initiatives on readmission: THA and TKA readmission rates. J Arthroplasty. 2015;30:2057–2060.CrossRefPubMed Keeney JA, Nam D, Johnson SR, Nunley RM, Clohisy JC, Barrack RL. The impact of risk reduction initiatives on readmission: THA and TKA readmission rates. J Arthroplasty. 2015;30:2057–2060.CrossRefPubMed
32.
go back to reference Keswani A, Lovy AJ, Robinson J, Levy R, Chen D, Moucha CS. Risk factors predict increased length of stay and readmission rates in revision joint arthroplasty. J Arthroplasty. 2016;31:603–608.CrossRefPubMed Keswani A, Lovy AJ, Robinson J, Levy R, Chen D, Moucha CS. Risk factors predict increased length of stay and readmission rates in revision joint arthroplasty. J Arthroplasty. 2016;31:603–608.CrossRefPubMed
33.
go back to reference Kiridly DN, Karkenny AJ, Hutzler LH, Slover JD, Iorio R, Bosco JA 3rd. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA). J Arthroplasty. 2014;29:1545–1547.CrossRefPubMed Kiridly DN, Karkenny AJ, Hutzler LH, Slover JD, Iorio R, Bosco JA 3rd. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA). J Arthroplasty. 2014;29:1545–1547.CrossRefPubMed
34.
go back to reference Kurtz SM, Lau EC, Baykal D, Springer BD. Outcomes of ceramic bearings after revision total hip arthroplasty in the Medicare population. J Arthroplasty. 2016;31:1979–1985.CrossRefPubMed Kurtz SM, Lau EC, Baykal D, Springer BD. Outcomes of ceramic bearings after revision total hip arthroplasty in the Medicare population. J Arthroplasty. 2016;31:1979–1985.CrossRefPubMed
35.
go back to reference Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Which hospital and clinical factors drive 30- and 90-day readmission after TKA? J Arthroplasty. 2016;31:2099–2107.CrossRefPubMed Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Which hospital and clinical factors drive 30- and 90-day readmission after TKA? J Arthroplasty. 2016;31:2099–2107.CrossRefPubMed
36.
37.
go back to reference Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60:217–220.CrossRefPubMed Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60:217–220.CrossRefPubMed
38.
go back to reference Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95:1801–1811.CrossRefPubMed Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95:1801–1811.CrossRefPubMed
39.
go back to reference Lim SJ, Yeo I, Park CW, Moon YW, Park YS. Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia. BMC Musculoskelet Disord. 2015;16:278.CrossRefPubMedPubMedCentral Lim SJ, Yeo I, Park CW, Moon YW, Park YS. Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia. BMC Musculoskelet Disord. 2015;16:278.CrossRefPubMedPubMedCentral
40.
go back to reference Martsolf GR, Barrett ML, Weiss AJ, Kandrack R, Washington R, Steiner CA, Mehrotra A, SooHoo NF, Coffey R. Impact of race/ethnicity and socioeconomic status on risk-adjusted hospital readmission rates following hip and knee arthroplasty. J Bone Joint Surg Am. 2016;98:1385–1391.CrossRefPubMed Martsolf GR, Barrett ML, Weiss AJ, Kandrack R, Washington R, Steiner CA, Mehrotra A, SooHoo NF, Coffey R. Impact of race/ethnicity and socioeconomic status on risk-adjusted hospital readmission rates following hip and knee arthroplasty. J Bone Joint Surg Am. 2016;98:1385–1391.CrossRefPubMed
41.
go back to reference McNair PD, Luft HS, Bindman AB. Medicare’s policy not to pay for treating hospital-acquired conditions: the impact. Health Aff (Millwood). 2009;28:1485–1493.CrossRefPubMed McNair PD, Luft HS, Bindman AB. Medicare’s policy not to pay for treating hospital-acquired conditions: the impact. Health Aff (Millwood). 2009;28:1485–1493.CrossRefPubMed
42.
go back to reference Ninomiya JT, Dean JC, Incavo SJ. What’s new in hip replacement. J Bone Joint Surg Am. 2015;97:1543–1551.CrossRefPubMed Ninomiya JT, Dean JC, Incavo SJ. What’s new in hip replacement. J Bone Joint Surg Am. 2015;97:1543–1551.CrossRefPubMed
43.
go back to reference Nouraie M, Gordeuk VR. Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis. Transfusion. 2015;55:2331–2338.CrossRefPubMedPubMedCentral Nouraie M, Gordeuk VR. Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis. Transfusion. 2015;55:2331–2338.CrossRefPubMedPubMedCentral
44.
go back to reference Oronce CI, Shao H, Shi L. Disparities in 30-day readmissions after total hip arthroplasty. Med Care. 2015;53:924–930.CrossRefPubMed Oronce CI, Shao H, Shi L. Disparities in 30-day readmissions after total hip arthroplasty. Med Care. 2015;53:924–930.CrossRefPubMed
45.
go back to reference Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 suppl 2):24–28.CrossRefPubMed Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 suppl 2):24–28.CrossRefPubMed
46.
go back to reference Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994.CrossRefPubMedPubMedCentral Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994.CrossRefPubMedPubMedCentral
47.
go back to reference Paxton EW, Inacio MC, Singh JA, Love R, Bini SA, Namba RS. Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system? Clin Orthop Relat Res. 2015;473:3446–3455.CrossRefPubMedPubMedCentral Paxton EW, Inacio MC, Singh JA, Love R, Bini SA, Namba RS. Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system? Clin Orthop Relat Res. 2015;473:3446–3455.CrossRefPubMedPubMedCentral
48.
go back to reference Plate JF, Brown ML, Wohler AD, Seyler TM, Lang JE. Patient factors and cost associated with 90-day readmission following total hip arthroplasty. J Arthroplasty. 2016;31:49–52.CrossRefPubMed Plate JF, Brown ML, Wohler AD, Seyler TM, Lang JE. Patient factors and cost associated with 90-day readmission following total hip arthroplasty. J Arthroplasty. 2016;31:49–52.CrossRefPubMed
49.
go back to reference Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty. 2013;28:1499–1504.CrossRefPubMed Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty. 2013;28:1499–1504.CrossRefPubMed
50.
go back to reference Ramkumar PN, Chu CT, Harris JD, Athiviraham A, Harrington MA, White DL, Berger DH, Naik AD, Li LT. Causes and rates of unplanned readmissions after elective primary total joint arthroplasty: a systematic review and meta-analysis. Am J Orthop (Belle Mead NJ). 2015;44:397–405.PubMed Ramkumar PN, Chu CT, Harris JD, Athiviraham A, Harrington MA, White DL, Berger DH, Naik AD, Li LT. Causes and rates of unplanned readmissions after elective primary total joint arthroplasty: a systematic review and meta-analysis. Am J Orthop (Belle Mead NJ). 2015;44:397–405.PubMed
51.
go back to reference Saucedo J, Marecek GS, Lee J, Huminiak L, Stulberg SD, Puri L. How accurately are we coding readmission diagnoses after total joint arthroplasty? J Arthroplasty. 2013;28:1076–1079.CrossRefPubMed Saucedo J, Marecek GS, Lee J, Huminiak L, Stulberg SD, Puri L. How accurately are we coding readmission diagnoses after total joint arthroplasty? J Arthroplasty. 2013;28:1076–1079.CrossRefPubMed
52.
go back to reference Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:464–470.CrossRefPubMed Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:464–470.CrossRefPubMed
53.
go back to reference Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN Jr, McCullough DL. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi: the American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. 1994;151:1648–1651.PubMed Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN Jr, McCullough DL. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi: the American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. 1994;151:1648–1651.PubMed
54.
go back to reference Sellers MM, Merkow RP, Halverson A, Hinami K, Kelz RR, Bentrem DJ, Bilimoria KY. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216:420–427.CrossRefPubMed Sellers MM, Merkow RP, Halverson A, Hinami K, Kelz RR, Bentrem DJ, Bilimoria KY. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216:420–427.CrossRefPubMed
55.
56.
go back to reference Silen W, Cope Z. Cope’s Early Diagnosis of the Acute Abdomen. New York, NY: Oxford University Press, USA; 2005. Silen W, Cope Z. Cope’s Early Diagnosis of the Acute Abdomen. New York, NY: Oxford University Press, USA; 2005.
57.
go back to reference Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults: Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:3110–3121.CrossRefPubMed Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults: Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:3110–3121.CrossRefPubMed
58.
go back to reference Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498; quiz 499. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498; quiz 499.
59.
go back to reference van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a systematic review. CMAJ. 2011;183:E391–402.CrossRefPubMedPubMedCentral van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a systematic review. CMAJ. 2011;183:E391–402.CrossRefPubMedPubMedCentral
60.
go back to reference Voskuijl T, Hageman M, Ring D. Higher Charlson comorbidity index scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res. 2014;472:1638–1644.CrossRefPubMed Voskuijl T, Hageman M, Ring D. Higher Charlson comorbidity index scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res. 2014;472:1638–1644.CrossRefPubMed
61.
go back to reference Watts CD, Houdek MT, Wagner ER, Lewallen DG, Mabry TM. Morbidly obese vs nonobese aseptic revision total hip arthroplasty: surprisingly similar outcomes. J Arthroplasty. 2016;31:842–845.CrossRefPubMed Watts CD, Houdek MT, Wagner ER, Lewallen DG, Mabry TM. Morbidly obese vs nonobese aseptic revision total hip arthroplasty: surprisingly similar outcomes. J Arthroplasty. 2016;31:842–845.CrossRefPubMed
62.
go back to reference Wera GD, Ting NT, Moric M, Paprosky WG, Sporer SM, Della Valle CJ. Classification and management of the unstable total hip arthroplasty. J Arthroplasty. 2012;27:710–715.CrossRefPubMed Wera GD, Ting NT, Moric M, Paprosky WG, Sporer SM, Della Valle CJ. Classification and management of the unstable total hip arthroplasty. J Arthroplasty. 2012;27:710–715.CrossRefPubMed
63.
go back to reference Yu S, Garvin KL, Healy WL, Pellegrini VD Jr, Iorio R. Preventing hospital readmissions and limiting the complications associated with total joint arthroplasty. J AmAcad Orthop Surg. 2015;23:e60–71.CrossRefPubMed Yu S, Garvin KL, Healy WL, Pellegrini VD Jr, Iorio R. Preventing hospital readmissions and limiting the complications associated with total joint arthroplasty. J AmAcad Orthop Surg. 2015;23:e60–71.CrossRefPubMed
64.
go back to reference Zmistowski B, Restrepo C, Hess J, Adibi D, Cangoz S, Parvizi J. Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am. 2013;95:1869–1876.CrossRefPubMed Zmistowski B, Restrepo C, Hess J, Adibi D, Cangoz S, Parvizi J. Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am. 2013;95:1869–1876.CrossRefPubMed
Metadata
Title
Are Readmissions After THA Preventable?
Authors
Douglas S. Weinberg, MD
Matthew J. Kraay, MD
Steven J. Fitzgerald, MD
Vasu Sidagam, MD
Glenn D. Wera, MD
Publication date
01-05-2017
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 5/2017
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-016-5156-x

Other articles of this Issue 5/2017

Clinical Orthopaedics and Related Research® 5/2017 Go to the issue